ABSI is up 9.79% today. Volume is 3.39M vs a 30-day average of 4.35M (0.78x).
Absci Corporation is scheduled to report earnings Thu, Nov 12, 2026. Analysts expect EPS of $-0.21 on revenue of about $741.7K. Stocks often move sharply on earnings day.
VANCOUVER, Wash. and NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics d…
Absci (ABSI) has drawn fresh attention after reporting positive interim Phase 1 data for ABS-201 in pattern hair loss, including an estimated half-life of at least 65 days for the…
Absci has posted very strong multi year share gains, and the jump in market value now raises a simple question for you as an investor. Is the current price still grounded in what …
Keybanc analyst Scott Schoenhaus maintains Absci (NASDAQ:ABSI) with a Overweight and raises the price target from $16 to $20.